|
US6693202B1
(en)
*
|
1999-02-16 |
2004-02-17 |
Theravance, Inc. |
Muscarinic receptor antagonists
|
|
US7056916B2
(en)
|
2002-11-15 |
2006-06-06 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Medicaments for the treatment of chronic obstructive pulmonary disease
|
|
PE20040950A1
(es)
*
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
|
|
US7220742B2
(en)
*
|
2004-05-14 |
2007-05-22 |
Boehringer Ingelheim International Gmbh |
Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
|
|
WO2006023457A1
(en)
*
|
2004-08-16 |
2006-03-02 |
Theravance, Inc. |
COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
|
|
US8429052B2
(en)
*
|
2005-07-19 |
2013-04-23 |
Lincoln National Life Insurance Company |
Method and system for providing employer-sponsored retirement plan
|
|
GB0516313D0
(en)
|
2005-08-08 |
2005-09-14 |
Argenta Discovery Ltd |
Azole derivatives and their uses
|
|
JP2009504624A
(ja)
|
2005-08-08 |
2009-02-05 |
アージェンタ ディスカバリー リミテッド |
ビシクロ［２．２．１］ヘプタ−７−イルアミン誘導体およびその使用
|
|
TW200738658A
(en)
|
2005-08-09 |
2007-10-16 |
Astrazeneca Ab |
Novel compounds
|
|
BRPI0614410A2
(pt)
*
|
2005-08-15 |
2011-03-29 |
Boehringer Ingelheim Int |
processo para preparação de betamiméticos
|
|
GB0602778D0
(en)
*
|
2006-02-10 |
2006-03-22 |
Glaxo Group Ltd |
Novel compound
|
|
TW200745067A
(en)
|
2006-03-14 |
2007-12-16 |
Astrazeneca Ab |
Novel compounds
|
|
TW200811104A
(en)
*
|
2006-04-25 |
2008-03-01 |
Theravance Inc |
Crystalline forms of a dimethylphenyl compound
|
|
TW200811105A
(en)
*
|
2006-04-25 |
2008-03-01 |
Theravance Inc |
Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
|
|
UY30542A1
(es)
*
|
2006-08-18 |
2008-03-31 |
Boehringer Ingelheim Int |
Formulacion de aerosol para la inhalacion de agonistas beta
|
|
ES2302447B1
(es)
*
|
2006-10-20 |
2009-06-12 |
Laboratorios Almirall S.A. |
Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
|
|
TW200833670A
(en)
|
2006-12-20 |
2008-08-16 |
Astrazeneca Ab |
Novel compounds 569
|
|
GB0702458D0
(en)
|
2007-02-08 |
2007-03-21 |
Astrazeneca Ab |
Salts 668
|
|
UY31905A
(es)
|
2008-06-18 |
2010-01-29 |
Astrazeneca Ab |
Derivados de benzoxazinona, procesos de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones.
|
|
TW201036957A
(en)
|
2009-02-20 |
2010-10-16 |
Astrazeneca Ab |
Novel salt 628
|
|
DK2400950T3
(da)
|
2009-02-26 |
2019-07-29 |
Glaxo Group Ltd |
Farmaceutiske formuleringer omfattende 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
|
|
EP2228368A1
(en)
|
2009-03-12 |
2010-09-15 |
Almirall, S.A. |
Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
|
|
MX2011011156A
(es)
|
2009-04-23 |
2011-11-04 |
Theravance Inc |
COMPUESTOS DIAMIDA QUE TIENE ACTIVIDAD COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS Y COMO AGONISTAS DE LOS RECEPTORES ANDRENERGICOS ß2.
|
|
US8877930B2
(en)
|
2009-11-04 |
2014-11-04 |
Massachusetts Institute Of Technology |
Continuous flow synthesis of amino alcohols using microreactors
|
|
WO2011061527A1
(en)
|
2009-11-17 |
2011-05-26 |
Astrazeneca Ab |
Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
|
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
|
WO2011081937A1
(en)
|
2009-12-15 |
2011-07-07 |
Gilead Sciences, Inc. |
Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy
|
|
WO2011109276A1
(en)
|
2010-03-01 |
2011-09-09 |
Massachussets Institute Of Technology |
Epoxidation catalysts
|
|
EP2386555A1
(en)
|
2010-05-13 |
2011-11-16 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
|
|
ITRM20110083U1
(it)
|
2010-05-13 |
2011-11-14 |
De La Cruz Jose Antonio Freire |
Piastra per la costruzione di carrelli per aeroplani
|
|
GB201016912D0
(en)
|
2010-10-07 |
2010-11-24 |
Astrazeneca Ab |
Novel combination
|
|
ME02297B
(me)
*
|
2011-06-10 |
2016-02-20 |
Chiesi Farm Spa |
Jedinjenja koja imaju aktivnost antagonista muskarinskih receptora i agonist beta2 adrenergičnog receptora
|
|
BR112013030302B1
(pt)
|
2011-06-10 |
2021-08-24 |
Chiesi Farmaceutici S.P.A. |
Composto, composição farmacêutica, uso de um composto, combinação de um composto e dispositivo
|
|
EP2578570A1
(en)
|
2011-10-07 |
2013-04-10 |
Almirall, S.A. |
Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
|
|
EP2592078A1
(en)
|
2011-11-11 |
2013-05-15 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
|
|
EP2641900A1
(en)
|
2012-03-20 |
2013-09-25 |
Almirall, S.A. |
Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
|
|
BR112015012730B1
(pt)
|
2012-12-06 |
2022-07-05 |
Chiesi Farmaceutici S.P.A. |
Composto, composição farmaceutica, dispositivo, uso de um composto e combinação
|
|
AR093832A1
(es)
|
2012-12-06 |
2015-06-24 |
Chiesi Farm Spa |
COMPUESTOS CON ACTIVIDAD ANTAGONISTA DE LOS RECEPTORES MUSCARINICOS Y ACTIVIDAD AGONISTA DEL RECEPTOR b2 ADRENERGICO
|
|
MA38260B1
(fr)
|
2012-12-18 |
2018-04-30 |
Almirall Sa |
Nouveaux dérivés de cyclohexyl et quinuclidinyl carbamate ayant une activité d'agoniste adrénergique beta2 et une activité d'antagoniste muscarinique m3
|
|
TWI643853B
(zh)
|
2013-02-27 |
2018-12-11 |
阿爾米雷爾有限公司 |
同時具有β2腎上腺素受體促效劑和M3毒蕈鹼受體拮抗劑活性之2-氨基-1-羥乙基-8-羥基喹啉-2(1H)-酮衍生物之鹽類
|
|
TW201517906A
(zh)
|
2013-07-25 |
2015-05-16 |
Almirall Sa |
含有ｍａｂａ化合物和皮質類固醇之組合
|
|
TWI641373B
(zh)
|
2013-07-25 |
2018-11-21 |
阿爾米雷爾有限公司 |
具有蕈毒鹼受體拮抗劑和β２腎上腺素受體促效劑二者之活性的２－胺基－１－羥乙基－８－羥基喹啉－２（１Ｈ）－酮衍生物之鹽
|
|
TW201617343A
(zh)
|
2014-09-26 |
2016-05-16 |
阿爾米雷爾有限公司 |
具有β２腎上腺素促效劑及Ｍ３蕈毒拮抗劑活性之新穎雙環衍生物
|
|
TWI703138B
(zh)
|
2015-02-12 |
2020-09-01 |
義大利商吉斯藥品公司 |
具有蕈毒鹼受體拮抗劑及β２腎上腺素受體促效劑活性之化合物
|
|
AR104828A1
(es)
|
2015-06-01 |
2017-08-16 |
Chiesi Farm Spa |
COMPUESTOS CON ACTIVIDAD ANTAGONISTA DE LOS RECEPTORES MUSCARÍNICOS Y ACTIVIDAD AGONISTA DEL RECEPTOR b2 ADRENÉRGICO
|
|
WO2017093208A1
(en)
|
2015-12-03 |
2017-06-08 |
Chiesi Farmaceutici S.P.A. |
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
|
|
EP3484879B1
(en)
|
2016-07-13 |
2020-12-30 |
Chiesi Farmaceutici S.p.A. |
Hydroxyquinolinone compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
|
|
WO2022111500A1
(en)
*
|
2020-11-26 |
2022-06-02 |
Rezubio Pharmaceuticals Co., Ltd |
Anticholinergic agents
|
|
CN113666906A
(zh)
*
|
2021-09-23 |
2021-11-19 |
安徽有吉医药科技有限公司 |
2-氯-1-(2,2-二甲基-4h-苯并[1,3]二噁英-6-基)乙酮的合成方法
|